Labcorp on Tuesday raised its annual profit forecast and beat estimates in the third quarter as the laboratory operator ...
Labcorp delivered mixed third-quarter results, with higher sales and raised profit | Labcorp reported solid third-quarter ...
The FDA has bestowed a green light to a companion diagnostic for Pfizer’s recently approved hemophilia B gene therapy—because, at a cost of $3.5 million per dose, you want to make sure it will work.
Test Expands Labcorp’s Leadership In Bringing Testing Solutions for New Precision Medicines Used to Treat Patients With Lung Cancer Photo courtesy of Labcorp. Labcorp’s oncology platform brings ...
Labcorp Holdings Inc. LH, or Labcorp, is slated to report its first-quarter 2025 results on April 29, before the opening bell. The renowned laboratory service provider reported adjusted earnings of $3 ...
Editor’s note: LimeLight is a new feature from WRAL TechWire offering another means of publishing noteworthy news. Be sure to check out more LimeLight worthy news at this link. BURLINGTON — Labcorp ...
The deal, worth $237.5 million, includes patient service centers and contracts, enhancing Labcorp's clinical laboratory offerings. Labcorp acquires BioReference Health's lab testing divisions in the U ...
LabCorp and Quest Diagnostics both said their average turnaround times for COVID-19 diagnostic tests now stand between one and three days. LabCorp said it has completed over 10 million COVID-19 tests ...
[Updated 5/15/2020] Is Quest Diagnostics Or LabCorp The Better Diagnostic Play In The COVID Era? As the U.S. re-opens its economy while trying to contain the spread of the contagious viral infection, ...
StockStory.org on MSN
Why Labcorp (LH) Stock Is Falling Today
What Happened? Shares of healthcare diagnostics company Labcorp Holdings (NYSE:LH) fell 3.8% in the morning session after the ...
BURLINGTON, N.C.--(BUSINESS WIRE)--Labcorp (NYSE: LH), a leading global life sciences company, today announced that Marcia Eisenberg, Ph.D., chief scientific officer of Labcorp Diagnostics, was ...
Test Expands Labcorp’s Leadership In Bringing Testing Solutions for New Precision Medicines Used to Treat Patients With Lung Cancer BURLINGTON, N.C.--(BUSINESS WIRE)--Labcorp ® (NYSE: LH), a leading ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results